N2 disease in non-small cell lung cancer patients, diagnosis and evaluation: a Turkish chest surgeon's perspective
Mediastinal or N2 disease is the most important factor in selecting the optimal treatment strategy in patients without distant metastasis. A direct surgical resection has not generally been accepted as a treatment modality inwhom mediastinal nodal involvement is demonstrated. Patients with lung canc...
Main Author: | Alper TOKER |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2008-10-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.05.022&path%5B%5D=144 |
Similar Items
-
Update in non small- cell lung cancer staging
by: RA Salgado, et al.
Published: (2013-05-01) -
The value of mediastinoscopy in the staging of lung cancer with clinical N2 disease
by: Hui ZHAO, et al.
Published: (2008-10-01) -
Mediastinotomía anterior: Modalidad diagnóstica predictiva en el cáncer de pulmón
by: José Quintana Marrero, et al.
Published: (1999-04-01) -
Prognostic Factors of N2 Stage Non-small Cell Lung Cancer after Surgery
by: Zhenyu YANG, et al.
Published: (2020-01-01) -
Expert Consensus on Adjuvant Therapy of Non-small Cell Lung Cancer from China Thoracic Surgeons (2018 Version)
by: Thoracic Surgery Committee on Adjuvant Therapy of Non-small Cell Lung Cancer
Published: (2018-10-01)